Medical Developments International Limited (ASX:MVP)

ASX:MVP Financials Overview

Financials in millions AUD. Fiscal year is July - June.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Revenue Revenue Growth	42.57	42.57	39.06	33.15	32.34	21.94
Revenue Growth	4.74%	8.99%	17.82%	2.51%	47.37%	-13.17%
Gross Profit Gross Profit Growth	30.67	30.67	28.24	24.37	22.21	15.21
Operating Income Operating Income Growth	2.39	2.39	0.14	-14.12	-17.3	-12.55
Net Income Net Income Growth	0.63	0.63	0.09	-40.99	-5.61	-12.41
Earnings Per Share EPS Growth	0.01	0.01	0.00	-0.47	-0.07	-0.17
EPS Growth	-	562.38%	-	-	-	-

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Respiratory Respiratory Growth	10.95	10.95	12.87	11.85	11.72	8.22
Pain Management Pain Management Growth	31.62	31.62	26.19	21.3	20.45	13.27
Total Total Growth	42.57	42.57	39.06	33.15	32.34	21.94

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Cash & Investments Cash & Investments Growth	21.37	21.37	17.84	9.74	24.66	20.4
Total Debt Total Debt Growth	1.67	1.67	1.99	2.29	2.56	2.81
Net Cash (Debt) Net Cash Growth	19.7	19.7	15.85	7.45	22.1	17.59
Net Cash Growth	30.96%	24.32%	112.74%	-66.30%	25.68%	-47.08%
Net Cash Per Share Net Cash Per Share Growth	0.17	0.17	0.14	0.09	0.26	0.25

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Operating Cash Flow Operating Cash Flow Growth	5.75	5.75	-0.04	-10.78	-16.5	-10.78
Capital Expenditures CapEx Growth	-0.48	-0.48	-0.44	-0.79	-1.78	-1.2
Free Cash Flow Free Cash Flow Growth	5.27	5.27	-0.49	-11.57	-18.28	-11.98
Free Cash Flow Growth	984.16%	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Gross Margin	72.05%	72.05%	72.32%	73.50%	68.69%	69.31%
Operating Margin	5.61%	5.61%	0.36%	-42.60%	-53.51%	-57.17%
Pretax Margin	1.18%	1.18%	0.43%	-99.33%	-23.17%	-72.50%
Profit Margin	1.47%	1.47%	0.24%	-123.66%	-17.34%	-56.54%
FCF Margin	12.38%	12.38%	-1.24%	-34.91%	-56.53%	-54.58%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 11, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
PE Ratio	96.24	71.09	659.17	-	-	-
Forward PE	40.80	65.83	22.54	208.39	208.39	208.39
P/FCF Ratio	10.90	8.45	-	-	-	-
PS Ratio	1.35	1.05	1.59	1.05	2.07	4.74

Data Source: S&P Global Market Intelligence Last updated: Aug 19, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 10, 2026

Data Sources Report a data error